Bio Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Bio Rad Laboratories
BIO Stock  USD 257.00  2.55  1.00%   
Bio Rad financial statements provide useful quarterly and yearly information to potential Bio Rad Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio Rad financial statements helps investors assess Bio Rad's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bio Rad's valuation are summarized below:
Gross Profit
1.4 B
Profit Margin
(0.72)
Market Capitalization
7.2 B
Enterprise Value Revenue
2.6866
Revenue
2.6 B
We have found one hundred twenty available fundamental signals for Bio Rad Laboratories, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Bio Rad's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 18th of March 2025, Market Cap is likely to grow to about 919.2 M. Also, Enterprise Value is likely to grow to about 1 B

Bio Rad Total Revenue

1.41 Billion

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 82.7 M, Interest Expense of 51.3 M or Selling General Administrative of 492 M, as well as many indicators such as Price To Sales Ratio of 3.79, Dividend Yield of 0.0 or PTB Ratio of 2.13. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Check out the analysis of Bio Rad Correlation against competitors.

Bio Rad Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets9.8 B9.4 B7.2 B
Slightly volatile
Short and Long Term Debt Total165.6 M174.3 M469.9 M
Very volatile
Other Current Liabilities151.9 M271.4 M236.1 M
Pretty Stable
Total Current Liabilities342.8 M467.8 M491.5 M
Slightly volatile
Total Stockholder Equity6.9 B6.6 B5.1 B
Slightly volatile
Property Plant And Equipment Net723 M688.6 M529.5 M
Slightly volatile
Retained Earnings7.8 B7.4 B4.9 B
Slightly volatile
Cash264.1 M488.1 M431.3 M
Pretty Stable
Non Current Assets Total5.9 B5.6 B5 B
Slightly volatile
Cash And Short Term Investments1.2 B1.2 B943.7 M
Slightly volatile
Net Receivables278.1 M452.5 M387 M
Slightly volatile
Common Stock Shares Outstanding29.1 M28.2 M28.8 M
Slightly volatile
Liabilities And Stockholders Equity9.8 B9.4 B7.2 B
Slightly volatile
Non Current Liabilities Total2.4 B2.3 B1.6 B
Slightly volatile
Inventory798 M760 M554.8 M
Slightly volatile
Other Current Assets29.2 M30.7 M123.8 M
Pretty Stable
Total Liabilities2.9 B2.8 B2.1 B
Slightly volatile
Property Plant And Equipment Gross1.9 B1.8 B887.1 M
Slightly volatile
Total Current Assets1.1 B1.2 B1.9 B
Slightly volatile
Short Term Debt34.2 M42.9 M41.9 M
Pretty Stable
Accounts Payable117.1 M122.3 M174.3 M
Very volatile
Intangible Assets193.5 M293.6 M217.6 M
Slightly volatile
Common Stock Total Equity2.6 K2.7 K784 K
Slightly volatile
Common Stock2.6 K2.7 K784 K
Slightly volatile
Long Term Debt1.3 B1.2 B573.4 M
Slightly volatile
Good Will343.6 M410.5 M390.6 M
Pretty Stable
Property Plant Equipment371.9 M573.4 M456.3 M
Slightly volatile
Current Deferred Revenue43.2 B41.1 B7.5 B
Slightly volatile
Other Liabilities2.4 B2.3 B1.1 B
Slightly volatile
Short Term Investments1.2 B1.2 B569.8 M
Slightly volatile
Net Tangible Assets11.1 B10.6 B5.6 B
Slightly volatile
Capital Surpluse366.5 M514.6 M346.2 M
Slightly volatile
Non Current Liabilities Other218 M177.2 M193.8 M
Slightly volatile
Deferred Long Term Asset Charges15.6 M17.8 M15.5 M
Slightly volatile
Long Term Debt Total1.1 B1.1 B590.8 M
Slightly volatile
Long Term Investments5.1 B4.8 B3.9 B
Slightly volatile
Short and Long Term Debt1.1 M1.2 M190.4 M
Slightly volatile
Cash And Equivalents549.9 M499.3 M482.5 M
Slightly volatile
Net Invested Capital7.2 B7.8 B5.2 B
Slightly volatile
Net Working Capital2 B2.6 B1.7 B
Slightly volatile
Capital Lease Obligations160.6 M173.1 M204.2 M
Slightly volatile

Bio Rad Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization82.7 M151.6 M136.4 M
Slightly volatile
Selling General Administrative492 M814 M733.7 M
Slightly volatile
Total Revenue1.4 B2.6 B2.1 B
Slightly volatile
Gross Profit787.9 M1.4 B1.2 B
Slightly volatile
Other Operating Expenses1.3 B2.3 B1.9 B
Slightly volatile
Cost Of Revenue625.6 M1.2 B962.7 M
Slightly volatile
Total Operating Expenses628.9 M1.1 B938.2 M
Slightly volatile
Research Development167.8 M295.9 M211.2 M
Slightly volatile
Minority Interest18 K18.9 K106.7 K
Slightly volatile
Non Operating Income Net Other54.1 M51.5 M22.4 M
Slightly volatile
Non Recurring353.2 M336.4 M180.8 M
Slightly volatile
Interest Income77.9 M82 M621.2 M
Pretty Stable
Reconciled Depreciation154.8 M151.6 M145.1 M
Pretty Stable
Extraordinary Items47.6 M44.1 M59.1 M
Slightly volatile
Selling And Marketing Expenses1.2 M1.3 M1.5 M
Slightly volatile

Bio Rad Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow276 M404.4 M458.9 M
Very volatile
Depreciation88.3 M151.6 M130.9 M
Slightly volatile
Capital Expenditures198.4 M189 M124.8 M
Slightly volatile
Total Cash From Operating Activities478 M455.2 M311.4 M
Slightly volatile
End Period Cash Flow293.4 M489.8 M433.8 M
Pretty Stable
Change Receivables82.3 M78.4 M32.6 M
Slightly volatile
Cash Flows Other Operating137.9 M145.2 M255.4 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.793.61143.2868
Slightly volatile
PTB Ratio2.131.41091.7935
Slightly volatile
Days Sales Outstanding87.3176.8469.165
Very volatile
Book Value Per Share244233174
Slightly volatile
Operating Cash Flow Per Share16.9416.133810.6927
Slightly volatile
Stock Based Compensation To Revenue0.02170.02070.0129
Slightly volatile
Capex To Depreciation1.41.431.0151
Very volatile
PB Ratio2.131.41091.7935
Slightly volatile
EV To Sales3.863.67933.3328
Slightly volatile
Inventory Turnover2.191.831.9106
Pretty Stable
Days Of Inventory On Hand149206192
Pretty Stable
Payables Turnover5.749.71057.7527
Slightly volatile
Sales General And Administrative To Revenue0.430.420.3778
Pretty Stable
Research And Ddevelopement To Revenue0.07630.11530.0951
Very volatile
Capex To Revenue0.07010.07360.0561
Very volatile
Cash Per Share43.7841.695632.3998
Slightly volatile
POCF Ratio15.220.361626.1936
Slightly volatile
Capex To Operating Cash Flow0.390.41520.542
Slightly volatile
Days Payables Outstanding58.4237.58848.0692
Slightly volatile
EV To Operating Cash Flow17.3820.744527.15
Slightly volatile
Intangibles To Total Assets0.140.07520.1264
Slightly volatile
Current Ratio2.32.58043.6958
Very volatile
Tangible Book Value Per Share218208152
Slightly volatile
Receivables Turnover3.784.925.344
Very volatile
Shareholders Equity Per Share244233174
Slightly volatile
Debt To Equity0.02520.02650.1896
Slightly volatile
Capex Per Share7.036.69884.3098
Slightly volatile
Revenue Per Share95.5190.965576.51
Slightly volatile
Interest Debt Per Share9.97.91117.4172
Very volatile
Debt To Assets0.01770.01860.1103
Slightly volatile
Graham Number1.1 K1.1 K507
Slightly volatile
Short Term Coverage Ratios10.0810.6107419
Very volatile
Operating Cycle292340269
Slightly volatile
Price Book Value Ratio2.131.41091.7935
Slightly volatile
Days Of Payables Outstanding58.4237.58848.0692
Slightly volatile
Price To Operating Cash Flows Ratio15.220.361626.1936
Slightly volatile
Company Equity Multiplier2.171.42541.5745
Slightly volatile
Long Term Debt To Capitalization0.01860.01960.1274
Slightly volatile
Total Debt To Capitalization0.02460.02580.1402
Slightly volatile
Debt Equity Ratio0.02520.02650.1896
Slightly volatile
Quick Ratio1.622.58042.7287
Pretty Stable
Dividend Paid And Capex Coverage Ratio1.752.40852.4391
Slightly volatile
Net Income Per E B T0.580.78730.7583
Very volatile
Cash Ratio0.410.70.8097
Pretty Stable
Operating Cash Flow Sales Ratio0.190.17740.1316
Slightly volatile
Days Of Inventory Outstanding149206192
Pretty Stable
Days Of Sales Outstanding87.3176.8469.165
Very volatile
Cash Flow Coverage Ratios2.652.61166.9418
Pretty Stable
Price To Book Ratio2.131.41091.7935
Slightly volatile
Fixed Asset Turnover5.493.72714.6421
Slightly volatile
Capital Expenditure Coverage Ratio1.752.40852.4391
Slightly volatile
Price Cash Flow Ratio15.220.361626.1936
Slightly volatile
Debt Ratio0.01770.01860.1103
Slightly volatile
Cash Flow To Debt Ratio2.652.61166.9418
Pretty Stable
Price Sales Ratio3.793.61143.2868
Slightly volatile
Asset Turnover0.260.27410.4742
Slightly volatile
Gross Profit Margin0.630.53730.5562
Pretty Stable
Price Fair Value2.131.41091.7935
Slightly volatile

Bio Rad Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap919.2 M875.4 M910.3 M
Slightly volatile
Enterprise Value1 B952.4 M991.5 M
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings27.7008
Cash And Short Term Investments1.2 B

Bio Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as revenue or net income, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue41.1 B43.2 B
Total Revenue2.6 B1.4 B
Cost Of Revenue1.2 B625.6 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.42  0.43 
Research And Ddevelopement To Revenue 0.12  0.08 
Capex To Revenue 0.07  0.07 
Revenue Per Share 90.97  95.51 
Ebit Per Revenue 0.10  0.08 

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio Stock

  0.87A Agilent TechnologiesPairCorr
  0.86ME 23Andme HoldingPairCorr

Moving against Bio Stock

  0.81DVAX Dynavax TechnologiesPairCorr
  0.7VALN Valneva SE ADR Earnings Call TodayPairCorr
  0.45EQ EquilliumPairCorr
  0.37VIGL Vigil NeurosciencePairCorr
  0.33DMAC DiaMedica TherapeuticsPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
How To Invest In Bio
Details
Is Bio Stock a good investment?
Details
What is Bio Rad's Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(65.37)
Revenue Per Share
90.965
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0155
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY